Magnesium trisilicate powder
Magnesium trisilicate is an inorganic compound that is used as an antacid in the treatment of peptic ulcers.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Magnesium trisilicate
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Magnesium trisilicate
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 1 · Trials: 2 · 1936–2026
Showing the 50 most relevant studies, sorted by most relevant.
International Journal of Toxicology, 2003
Guerrero-Romero F, Micke O, Simental-Mendía LE, et al.
2023
A large amount of published research points to the interesting concept (hypothesis) that magnesium (Mg) status may have relevance for the outcome of COVID-19 and that Mg could be protective during the COVID disease course. As an essential element, Mg plays basic biochemical, cellular, and physiological roles required for cardiovascular, immunological, respiratory, and neurological functions. Both low serum and dietary Mg have been associated with the severity of COVID-19 outcomes, including mortality; both are also associated with COVID-19 risk factors such as older age, obesity, type 2 diabetes, kidney disease, cardiovascular disease, hypertension, and asthma. In addition, populations with high rates of COVID-19 mortality and hospitalization tend to consume diets high in modern processed foods, which are generally low in Mg. In this review, we review the research to describe and consider the possible impact of Mg and Mg status on COVID-19 showing that (1) serum Mg between 2.19 and 2.26 mg/dL and dietary Mg intakes > 329 mg/day could be protective during the disease course and (2) inhaled Mg may improve oxygenation of hypoxic COVID-19 patients. In spite of such promise, oral Mg for COVID-19 has thus far been studied only in combination with other nutrients. Mg deficiency is involved in the occurrence and aggravation of neuropsychiatric complications of COVID-19, including memory loss, cognition, loss of taste and smell, ataxia, confusion, dizziness, and headache. Potential of zinc and/or Mg as useful for increasing drug therapy effectiveness or reducing adverse effect of anti-COVID-19 drugs is reviewed. Oral Mg trials of patients with COVID-19 are warranted.
Abstract licence: CC BY
Ab Rahim SN, Nordin N, Wan Omar WFA, et al.
2023
Magnesium (Mg2+) is a predominantly intracellular cation that plays significant roles in various enzymatic, membrane, and structural body functions. As a calcium (Ca2+) antagonist, it is imperative for numerous neuromuscular activities. The imbalance of body Mg2+ concentration leads to clinical manifestations ranging from asymptomatic to severe life-threatening complications. Therefore, the contribution of Mg2+ measurement regarding various laboratory and clinical aspects cannot be ignored. Mg2+ is often described as the forgotten analyte. However, its close relationship with body potassium (K+), Ca2+, and phosphate homeostasis proves that Mg2+ imbalance could co-exist as the root cause or the consequence of other electrolyte disorders. Meanwhile, several preanalytical, analytical, and postanalytical aspects could influence Mg2+ measurement. This review highlights Mg2+ measurement's laboratory and clinical issues and some analyte disturbances associated with its imbalance. Understanding this basis could aid clinicians and laboratory professionals in Mg2+ result interpretation and patient management.
Abstract licence: CC BY
Li L, Li Q, Xiao A, et al.
2025
- Cadmium
- Soil
- Soil Pollutants
The application of soil amendments is crucial for mitigating cadmium (Cd) phytoavailability in Cd-contaminated paddy fields, thereby promoting safer rice production. However, the mechanisms through which these amendments influence phytoavailable Cd by modifying soil properties have not yet been fully elucidated. A pot experiment was conducted to evaluate the effects of three soil amendments-sepiolite (SE), wollastonite (WO), and a composite (YY)-on the Cd concentrations in brown rice, soil Cd fractions, soil properties, and bacterial community structure. Additionally, the relationships among brown rice Cd concentration, soil properties, Cd speciation, and bacterial diversity were explored. The findings demonstrated that the YY, SE, and WO amendments significantly increased the soil pH, cation exchange capacity (CEC), and concentrations of exchangeable calcium (ExCa), magnesium (ExMg), and available silicon (ASi), facilitating the transformation of water-soluble and acid-extractable forms of Cd into reducible fractions and facilitating the formation of low-solubility Cd compounds, thereby significantly lowering the levels of CaCl2-extractable Cd and DTPA-extractable Cd. The YY amendment also increased available potassium (AK) and available phosphorus (AP) while simplifying the bacterial community structure, notably increasing the abundance of Firmicutes and Bacteroidota. In contrast, SE amendment increased the abundance of Acidobacteriota. Both the YY and SE amendments reduced Cd phytoavailability by modifying Cd speciation and optimizing soil bacterial communities, whereas WO primarily lowered Cd phytoavailability by altering Cd speciation alone. These results underscore the regulatory role of soil amendments in modifying soil properties, influencing Cd speciation, and reshaping bacterial communities, ultimately reducing Cd accumulation in brown rice. This study enhances our understanding of the mechanisms by which amendments alter soil properties to reduce Cd phytoavailability, offering insights for developing in situ passivation technologies for Cd-contaminated soils.
Abstract licence: CC BY
Wang X, Zhu Y, Mu B, et al.
2023
- Phosphates
- Bone Cements
- Calcium Phosphates
Pennoyer, Cleota A.
2023
Tudorache Trifa DI, Bîrcă AC, Burdușel AC, et al.
2026
- Silicon Dioxide
- Anti-Infective Agents
- Pesticides
Reactions Weekly, 2024
Manoj Acharya, Satyaki Aparajit Mishra, Rudra Narayan Sahoo, et al.
Acta chimica slovenica, 2017
- Chemistry, Pharmaceutical
- Freeze Drying
- Calorimetry, Differential Scanning
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Maged Younes, Peter Aggett, et al.
EFSA Journal, 2018
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
70 found
Half-life
16-20 hours
Mechanism
The gelatinous silicon dioxide, formed by the reaction of magnesium trisilicate…
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
Half-life
16-20 hours
Protein binding
33%
Volume of distribution
Elimination
Clearance
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
Relieving indigestion and heartburn.
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 1295 interactions
How the body processes this drug — absorption, distribution, metabolism, and elimination
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Magnesium trisilicate
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Linked open data from Wikidata (Q836952), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.